Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $731.51 billion, total revenue of $169.58 billion and a weighted average PE ratio of 43.67.
Market Cap
731.51B
Revenue
169.58B
Profits
16.75B
PE Ratio
43.67
Profit Margin
9.88%
Dividend Yield
0.22%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 193.58B | 0.19% | 2,030,768 | 44.56B |
| 2 | DHR | Danaher Corporation | 148.95B | 0.61% | 5,242,138 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 52.29B | -0.60% | 798,221 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 34.31B | 0.34% | 4,333,140 | 7.07B |
| 5 | WAT | Waters Corporation | 31.33B | -1.07% | 2,117,266 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 30.34B | 4.79% | 5,205,829 | 16.31B |
| 7 | NTRA | Natera, Inc. | 29.06B | -3.73% | 2,759,492 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 27.78B | -0.76% | 252,868 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 23.82B | 0.77% | 640,333 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.28B | 0.38% | 1,058,729 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 20.56B | 5.54% | 4,008,460 | 4.34B |
| 12 | EXAS | Exact Sciences Corporation | 19.73B | 0.13% | 2,679,307 | 3.25B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.82B | 1.04% | 421,943 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 12.32B | -4.15% | 1,924,670 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 10.99B | -0.71% | 1,100,573 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 10.26B | 1.47% | 1,286,223 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.79B | 1.73% | 1,198,180 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 8.26B | 1.89% | 1,383,287 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 5.40B | -3.16% | 1,113,271 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.62B | -1.34% | 1,898,465 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.49B | 6.89% | 380,842 | 254.14M |
| 22 | VCYT | Veracyte, Inc. | 2.91B | -5.57% | 1,049,576 | 517.15M |
| 23 | TWST | Twist Bioscience Corporation | 2.88B | -3.67% | 774,785 | 391.56M |
| 24 | NEOG | Neogen Corporation | 2.44B | -0.80% | 2,825,075 | 880.32M |
| 25 | WGS | GeneDx Holdings Corp. | 2.33B | -2.05% | 803,978 | 427.54M |
| 26 | GRAL | GRAIL, Inc. | 2.15B | -8.38% | 1,945,345 | 147.17M |
| 27 | NEO | NeoGenomics, Inc. | 1.28B | -3.34% | 1,465,940 | 727.33M |
| 28 | CDNA | CareDx, Inc. | 964.88M | -0.32% | 661,251 | 379.81M |
| 29 | OPK | OPKO Health, Inc. | 921.24M | - | 3,819,750 | 606.88M |
| 30 | CSTL | Castle Biosciences, Inc. | 879.15M | -7.25% | 927,027 | 344.23M |
| 31 | PSNL | Personalis, Inc. | 804.57M | 0.33% | 3,148,093 | 69.65M |
| 32 | FLGT | Fulgent Genetics, Inc. | 473.89M | -38.09% | 2,620,789 | 322.67M |
| 33 | MYGN | Myriad Genetics, Inc. | 431.07M | -5.14% | 2,131,229 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 284.57M | -5.05% | 323,888 | 92.39M |
| 35 | BNR | Burning Rock Biotech Limited | 278.10M | 8.26% | 13,915 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 193.32M | 6.00% | 101,077 | 4.40M |
| 37 | MDXH | MDxHealth SA | 174.64M | -4.23% | 218,108 | 107.88M |
| 38 | BDSX | Biodesix, Inc. | 121.96M | 7.81% | 377,916 | 88.50M |
| 39 | FONR | FONAR Corporation | 121.94M | 0.16% | 66,382 | 106.03M |
| 40 | XGN | Exagen Inc. | 82.04M | -4.74% | 193,420 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 42.19M | -0.91% | 18,512 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 11.88M | -0.61% | 10,104 | - |
| 43 | NOTV | Inotiv, Inc. | 9.31M | -0.73% | 260,839 | 514.03M |
| 44 | XWEL | XWELL, Inc. | 8.59M | 9.56% | 68,291,667 | 29.52M |
| 45 | MYNZ | Mainz Biomed N.V. | 8.20M | 3.15% | 182,925 | 659.94K |
| 46 | ADVB | Advanced Biomed Inc. | 5.54M | 1.31% | 13,322 | - |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.84M | 5.87% | 90,443 | - |
| 48 | BIAF | bioAffinity Technologies, Inc. | 4.76M | 1.92% | 45,534 | 6.78M |
| 49 | ISPC | iSpecimen Inc. | 2.44M | -9.09% | 359,401 | 3.35M |